Amgen Inc. $AMGN Stock Holdings Decreased by Richard Bernstein Advisors LLC

Richard Bernstein Advisors LLC significantly reduced its stake in Amgen Inc. (NASDAQ:AMGN) by 64.9% in Q3, selling 8,655 shares. Despite this, other hedge funds increased their holdings, and Amgen beat quarterly earnings estimates, announcing a $2.52 quarterly dividend and setting positive FY2026 EPS guidance. Analysts generally maintain a “Hold” rating with a consensus price target of $354.00, though potential policy changes could pose long-term risks.